NAD+ Supplements for Men 40+
This report synthesizes current human clinical data on NAD+ precursors tailored for men over 40. While preclinical data is robust, human evidence is emerging and highly specific.
Written By
Muscle Velocity Research Team
Men's Health & Longevity Specialists
Medically Reviewed By
Dr. Robert K. Lee
MD, Endocrinology
This guide is part of our testosterone science track. For continuity, read testosterone and cholesterol and optimizing testosterone.
Effective at Boosting NAD+
Oral supplementation with NR and NMN consistently raises blood NAD+ levels in men aged 40+, typically doubling levels within 2-4 weeks.
Metabolic Focus
Strongest clinical signals for Men 40+ are in metabolic health (insulin sensitivity), particularly for those overweight or pre-diabetic.
Safety Profile
Studies up to 1 year show excellent safety for doses up to 1g/day. Main concerns are cost, product purity, and regulatory status.
Why Supplement? The NAD+ Decline
"By age 50, NAD+ levels in tissue can drop by ~50% compared to age 20. This decline correlates with mitochondrial dysfunction and metabolic stress."
Supplementation restores levels to youthful baselines, but the clinical focus is on health-span, not just numbers.
The Molecule Landscape
Comparing the primary precursors available on the market.
Evidence Dashboard
Interactive analysis of clinical outcomes. Select a domain to see the strength of evidence.
Metabolic Health
Clinical Summary
Strongest signal for NAD+ boosters. NMN has demonstrated improved muscle insulin sensitivity in pre-diabetic women. Data for healthy, non-obese men is less compelling but suggests preventative value.
Key Peer-Reviewed Studies
- Yoshino et al. (Science, 2021): NMN (250mg) increased muscle insulin sensitivity in prediabetic women.
- Dollerup et al. (2018): NR (2g) did not improve insulin sensitivity in obese men, suggesting ceiling effects.
- Igarashi et al. (2022): NMN reduced arterial stiffness in middle-aged adults with high BMI.
Protocol & Safety
Practical guidance based on current clinical practices.
Clinical Dose Estimator
Drag the slider to visualize expected outcomes and economic impact of NR/NMN supplementation.
Low Dose Entry
250-300mgStandard entry dose used in early safety trials. Sufficient to raise blood NAD+ by ~40-50%. Good starting point for preventative support.
Safety & Precautions
Active Cancer
Theoretical risk that NAD+ fuels tumor growth. Avoid supplementation if undergoing active cancer treatment unless specifically cleared by oncology.
Methylation Balance
High dose NR/NMN may deplete methyl groups (homocysteine rise). Experts suggest adding TMG to support the methylation cycle during high-dose protocols.
Circadian Optimization
Take in the morning. NAD+ synthesis follows circadian rhythms (SIRT1 is clock-regulated). Late-day dosing may disrupt normal sleep architecture.
"Always source from batches tested for purity (>99%) and stabilized for shelf life, as NAD+ precursors can degrade rapidly."
The Bottom Line for Men 40+
NAD+ supplementation is scientifically promising but not a magic bullet. It is most likely to benefit men with existing metabolic strain (overweight, pre-diabetic) or older adults (>60). For fit, healthy men in their 40s, effects may be subtle or preventative.